Author(s):
Omkar Salunkhe, Namdeo Jadhav, Ashok Hajare, Shiju Sebastian, Punam Kumari, Puja Malhotra
Email(s):
omkarsalunkhekvv@outlook.com
DOI:
10.52711/0974-360X.2025.00496 
Address:
Omkar Salunkhe1*, Namdeo Jadhav2, Ashok Hajare3, Shiju Sebastian4, Punam Kumari5, Puja Malhotra6
1,2Krishna Institute of Pharmacy, Krishna Vishwa Vidyapeeth Karad, Maharashtra, India – 415539.
3Bharati Vidyapeeth College of Pharmacy Palus, Maharashtra, India – 416313.
4Christ Deemed to be University, Bangalore, Karnataka, India – 560029.
5School of Computer Science Engineering and Technology, Bennett University, GN (UP), India – 201310.
6Faculty of Dental Sciences, SGT University, Gurugram, Haryana, India – 122505.
*Corresponding Author
Published In:
Volume - 18,
Issue - 7,
Year - 2025
ABSTRACT:
Nanolipid-based drug delivery systems are a new milestone to be achieved in the field of pharmaceutical science as it integrates the advantages of lipid carriers with nanoscale features. The oral administration of such systems promises better drug bioavailability, targeted delivery, and novel sustained release profiles which help in overcoming the physiological hurdles posed by the gastrointestinal tract. Formulation stability and therapeutic efficacy have recently seen improvement alongside promising preclinical results. Regulatory frameworks are also starting to appreciate the potential these novel carriers offer. There seems to be a paradigm shift as evolution in the field would foster intelligent personalized therapies for increased patient care. Enhanced therapy will integrate smart delivery systems alongside scalable nanolipid system manufacturing.
Cite this article:
Omkar Salunkhe, Namdeo Jadhav, Ashok Hajare, Shiju Sebastian, Punam Kumari, Puja Malhotra. Oral Delivery of Lipid Nanosystem: Pharmacokinetics and Pharmacodynamic Advances. Research Journal of Pharmacy and Technology. 2025;18(7):3444-2. doi: 10.52711/0974-360X.2025.00496
Cite(Electronic):
Omkar Salunkhe, Namdeo Jadhav, Ashok Hajare, Shiju Sebastian, Punam Kumari, Puja Malhotra. Oral Delivery of Lipid Nanosystem: Pharmacokinetics and Pharmacodynamic Advances. Research Journal of Pharmacy and Technology. 2025;18(7):3444-2. doi: 10.52711/0974-360X.2025.00496 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2025-18-7-76
REFERENCES:
1. Negi JS. Nanolipid Materials for Drug Delivery Systems: A Comprehensive Review in Characterization and Biology of Nanomaterials for Drug Delivery: Nanoscience and Nanotechnology in Drug Delivery, Elsevier, 2018, pp. 137–163. doi: 10.1016/B978-0-12-814031-4.00006-4.
2. Niu L, Li Z, Fan F, Zhong X, Peng M, and Liu Z. Nano-strategies for enhancing the bioavailability of tea polyphenols: preparation, applications, and challenges. Foods. 2022; 11(3):387.
3. Quach H. Le TV, Nguyen TT, et al. Nano-lipids based on ginger oil and lecithin as a potential drug delivery system. Pharmaceutics. 2022; 14(8):54. doi: 10.3390/pharmaceutics14081654.
4. Zafar A, Alruwaili NK, Imam SS, et al., Development and optimization of nanolipid-based formulation of diclofenac sodium: in vitro characterization and preclinical evaluation. Pharmaceutics. 2022; 14(3):507. doi: 10.3390/pharmaceutics14030507.
5. Barba AA, Bochicchio S, Bertoncin P, et al. Coating of nanolipid structures by a novel simil-microfluidic technique: Experimental and theoretical approaches. Coatings. 2019; 9(8):491.
6. Nahak P, Karmarkar G, Roy B, et al. Physicochemical studies on local anaesthetic loaded second generation nanolipid carriers. 2015; 5(33): 26061–26070. doi: 10.1039/c4ra16434b.
7. Subramaniam V, Siddik ZH, and Nagoor NH. Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations. Journal of Nanoparticle Research. 2020; 22:141. doi: 10.1007/s11051-020-04848-0.
8. Pople PV and Singh KK. Development and evaluation of colloidal modified nanolipid carrier: Application to topical delivery of tacrolimus. European Journal of Pharmaceutics and Biopharmaceutics. 2011; 79(1): 82–94. doi: 10.1016/j.ejpb.2011.02.016.
9. Kaur P, Garg T, Rath G, et al. Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design. Drug Delivery. 2016; 23(6): 1912–1925. doi: 10.3109/10717544.2014.993486.
10. Vohra T, Kaur I, Heer H, et al. Nanolipid carrier-based thermoreversible gel for localized delivery of docetaxel to breast cancer. Cancer Nanotechnology. 2013; 4(1–3):1–12. doi: 10.1007/s12645-013-0032-9.
11. M. Zhang, Xiao B, Wang H, et al. Edible ginger-derived nano-lipids loaded with doxorubicin as a novel drug-delivery approach for colon cancer therapy. Molecular Therapy. 2016; 24(10); 1783–1796. doi: 10.1038/mt.2016.159.
12. Ghazizadeh E and Nasery Z. The viewpoint of nanolipid vesicles (liposomes, exosomes, and microvesicles) as biosensors in medical health advances. Frontiers Nanotechnology. 2023, 5: 1230407. doi: 10.3389/fnano.2023.1230407.
13. Zhang M, Wang X, Han MK, et al. Oral administration of ginger-derived nanolipids loaded with siRNA as a novel approach for efficient siRNA drug delivery to treat ulcerative colitis. Nanomedicine. 2017; 12(16): 1927–1943. doi: 10.2217/nnm-2017-0196.
14. Lim WM, Rajinikanth PS, Mallikarjun C, et al. Formulation and delivery of itraconazole to the brain using a nanolipid carrier system. International Journal of Nanomedicine. 2014; 9(1): 2117–2126. doi: 10.2147/IJN.S57565.
15. Abu Elella MH, Al Khatib AO, and Al-Obaidi H. Spray-dried nanolipid powders for pulmonary drug delivery: A comprehensive mini review. 2024; 16(5): 680. doi: 10.3390/pharmaceutics16050680.
16. Tamjidi F, Shahedi M, Varshosaz J, et al. Stability of astaxanthin-loaded nanostructured lipid carriers as affected by pH, ionic strength, heat treatment, simulated gastric juice and freeze–thawing. Journal of Food Science Technology. 2017; 54(10): 3132–3141. doi: 10.1007/s13197-017-2749-7.
17. Hasibi F, Nasirpour A, García-Manriqueet P, et al. Effects of thermal processing and pH on the physicochemical properties, stability, and structure of taxifolin-loaded nanostructured lipid carriers. Applied Food Research. 2024; 4(2): 100563. doi: 10.1016/j.afres.2024.100563.
18. Ravindran S. Suthar JK, Rokade, et al. Pharmacokinetics, metabolism, distribution and permeability of nanomedicines. Current Drug Metabolism. 2 018; 19(4): 327-334.
19. Mahor AK, Singh PP, Gupta R, et al. Nanostructured lipid carriers for improved delivery of therapeutics via the oral route. Journal of Nanotechnology. 2023; 687959. doi: 10.1155/2023/4687959.
20. Javed S, Mangla B, Almoshari Y, et al. Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery. Nanotechnology Reviews. 2022; 11: 1744–1777. doi: 10.1515/ntrev-2022-0109.
21. Williams HD, Trevaskis NL, Yeap YY, et al. Lipid-based formulations and drug supersaturation: Harnessing the unique benefits of the lipid digestion/absorption pathway. Pharmaceutical Research. 2013; 30: 2976–2992. doi: 10.1007/s11095-013-1126-0.
22. Jia L, Zhang D, Li Z, et al. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies. Colloids Surface B Biointerfaces. 2010; 80(2): 213–218.
23. Nguyen TTL and Maeng HJ. Pharmacokinetics and pharmacodynamics of intranasal solid lipid nanoparticles and nanostructured lipid carriers for nose-to-brain delivery. Pharmaceutics. 2022 Mar 5; 14(3): 572. doi: 10.3390/pharmaceutics14030572.
24. Jaiswal P, Gidwani B, Vyas A, et al. Nanostructured lipid carriers and their current application in targeted drug delivery. Artificial Cells, Nanomedicine, and Biotechnology. 2016; 44(1): 27-40; doi: 10.3109/21691401.2014.909822.
25. Susan R, Ionescu D, Suciu O, et al. Drug delivery systems for lymphatic uptake. Revista de Chimie. 2017; 68(12):2902-2906.
26. Wathoni N, Suhandi C, Elamin KM, et al. Advancements and challenges of nanostructured lipid carriers for wound healing applications. International Journal of Nanomedicine. 2024;15(19): 8091–8113. doi:10.2147/IJN.S478964.
27. 28. López KL, Ravasio A, González-Aramundiz JV, et al. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) prepared by microwave and ultrasound-assisted synthesis: promising green strategies for the nanoworld. Pharmaceutics. 2023; 15(5): 1333. doi: 10.3390/pharmaceutics15051333.
28. Csóka I, Ismail R, Jójárt-Laczkovich O, and Pallagi E. Regulatory considerations, challenges and risk-based approach in nanomedicine development. Current Medicinal Chemistry. 2021; 28(36): 7461–7476. doi: 10.2174/0929867328666210406115529.
29. Prajapati SK, Jain A, and Bajpai M. Lipid-based nanoformulations in onychomycosis therapy: addressing challenges of current therapies and advancing treatment. RSC Advances. 2025: 10, doi: 10.1039/d5ra00387c.